C. McKitrick

DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes

Angelo J. Canty, J. Keith Jones, A. Paterson, 2020, Clinical Epigenetics.

The 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) score and diabetes risk in the Diabetes Prevention Program Outcomes Study (DPPOS)

Michael S. Reidy, Shawn S. Stephens, Bartholomew E. Clark, 2022, BMC Nutrition.

Association of Metformin With the Development of Age-Related Macular Degeneration.

Michael S. Reidy, Shawn S. Stephens, Jeong W. Pak, 2022, JAMA ophthalmology.

The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS Experience

Michael S. Reidy, Shawn S. Stephens, Jeong W. Pak, 2022, Diabetes Care.

Genetic Modulation of Lipid Profiles following Lifestyle Modification or Metformin Treatment: The Diabetes Prevention Program

Michael S. Reidy, Bartholomew E. Clark, Denise R. Anderson, 2012, PLoS genetics.

DNA methylation age calculators reveal association with diabetic neuropathy in type 1 diabetes

Angelo J. Canty, J. Keith Jones, A. Paterson, 2020, Clinical Epigenetics.

Oxidative Stress and Cardiovascular Risk in Type 1 Diabetes Mellitus: Insights From the DCCT/EDIC Study

J. Keith Jones, A. Paterson, S. Mudaliar, 2018, Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease.

Glycemic control in diabetes mellitus: have changes in therapy made a difference?

D. Singer, D. Nathan, M. Larkin, 1996, The American journal of medicine.

Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH

Michael S. Reidy, Tanya M. Teslovich, Anne W. Ndungu, 2023, Diabetologia.

Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).

P A Cleary, M. Goldbaum, S. Schwartz, 2001, The Journal of pediatrics.

Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.

D. Nathan, D. Simon, M. Larkin, 1996, The American journal of medicine.